Literature DB >> 1384224

Nodular sclerosing Hodgkin's disease and large cell lymphoma. Immunophenotypic characterization of a composite case.

M Paulli1, R Rosso, S Kindl, E Boveri, M Sirchi, A De Medici, R Invernizzi, U Magrini.   

Abstract

Composite lymphomas have rarely been reported in Hodgkin's disease (HD), except in the lymphocyte predominance sub-type, and immunohistochemical investigations have been performed in only few cases. We describe the histological and immunophenotypical findings in a case of composite nodular sclerosing HD and high-grade, large cell non-Hodgkin's lymphoma (NHL). In our case HD and NHL cells displayed striking morphological and immunophenotypical divergence, suggesting a lack of correlation between the two neoplasms.

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1384224     DOI： 10.1007/bf01611185

Source DB:  PubMed          Journal:  Virchows Arch A Pathol Anat Histopathol        ISSN： 0174-7398


  20 in total

1.  Monoclonal antibodies in the diagnosis of Hodgkin's disease. The search for a rational panel.

Authors:  S M Chittal; P Caverivière; R Schwarting; J Gerdes; T Al Saati; F Rigal-Huguet; H Stein; G Delsol
Journal:  Am J Surg Pathol       Date:  1988-01       Impact factor: 6.394

2.  Leu-M1 antigen expression in advanced (tumor) stage mycosis fungoides.

Authors:  R Wieczorek; M Suhrland; D Ramsay; M L Reed; D M Knowles
Journal:  Am J Clin Pathol       Date:  1986-07       Impact factor: 2.493

3.  A comparison of three immunoperoxidase techniques for antigen detection in colorectal carcinoma tissues.

Authors:  Z R Shi; S H Itzkowitz; Y S Kim
Journal:  J Histochem Cytochem       Date:  1988-03       Impact factor: 2.479

4.  Nodular lymphocyte predominance type of Hodgkin's disease is a B cell lymphoma.

Authors:  S Poppema; W Timens; L Visser
Journal:  Adv Exp Med Biol       Date:  1985       Impact factor: 2.622

5.  Morphological studies of 84 untreated patients subjected to laparotomy for the staging of non-Hodgkin's lymphomas.

Authors:  H Kim; R F Dorfman
Journal:  Cancer       Date:  1974-03       Impact factor: 6.860

Review 6.  Non-Hodgkin's lymphoma occurring after Hodgkin's disease. Four new cases and a review of the literature.

Authors:  C Jacquillat; D Khayat; J P Desprez-Curely; M Weil; C Brocheriou; G Auclerc; N Chamseddine; J Bernard
Journal:  Cancer       Date:  1984-02-01       Impact factor: 6.860

7.  Morphological and immunohistochemical investigation of non-Hodgkin's lymphoma combined with Hodgkin's disease.

Authors:  M L Hansmann; C Fellbaum; P K Hui; K Lennert
Journal:  Histopathology       Date:  1989-07       Impact factor: 5.087

8.  A6--a new 45RO monoclonal antibody for immunostaining of paraffin-embedded tissues.

Authors:  E Berti; G G Aversa; D Soligo; G Cattoretti; D Delia; A Aiello; C Parravicini; B M Hall; R Caputo
Journal:  Am J Clin Pathol       Date:  1991-02       Impact factor: 2.493

9.  Anaplastic large cell lymphoma, CD30/Ki-1 positive, expressing the CD15/Leu-M1 antigen. Immunohistochemical and morphological relationships to Hodgkin's disease.

Authors:  R Rosso; M Paulli; U Magrini; S Kindl; E Boveri; G Volpato; S Poggi; P Baglioni; S Pileri
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1990

10.  Relationship of histopathologic features to survival and relapse in nodular sclerosing Hodgkin's disease. A study of 1659 patients.

Authors:  K A MacLennan; M H Bennett; A Tu; B V Hudson; M J Easterling; G V Hudson; A M Jelliffe
Journal:  Cancer       Date:  1989-10-15       Impact factor: 6.860
View more
  2 in total

Review 1.  Composite diffuse large B-cell lymphoma and classical Hodgkin's lymphoma of the stomach: case report and literature review.

Authors:  Hong-Wei Wang; Wen Yang; Lin Wang; Yun-Long Lu; Jiang-Yang Lu
Journal:  World J Gastroenterol       Date:  2013-10-07       Impact factor: 5.742

Review 2.  Composite lymphoma in the anterior mediastinum: a case report and review of the literature.

Authors:  Guohua Yu; Lingling Kong; Guimei Qu; Qian Zhang; Wei Wang; Lei Jiang
Journal:  Diagn Pathol       Date:  2011-07-06       Impact factor: 2.644
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.